Alterations in transcript abundance of bovine oocytes recovered at growth and dominance phases of the first follicular wave by Ghanem, Nasser et al.
BioMed  Central
Page 1 of 19
(page number not for citation purposes)
BMC Developmental Biology
Open Access Research article
Alterations in transcript abundance of bovine oocytes recovered at 
growth and dominance phases of the first follicular wave
Nasser Ghanem1, Michael Hölker1, Franca Rings1, Danyel Jennen1, 
Ernst Tholen1, Marc-André Sirard2, Helmut Torner3, Wilhelm Kanitz3, 
Karl Schellander1 and Dawit Tesfaye*1
Address: 1Institute of Animal Science, Animal Breeding and Husbandry Group, University of Bonn, 53115 Bonn, Germany, 2Centre de Recherche 
en Biologie de la Reproduction, Université Laval, Département des Sciences Animales, Pav. Comtois, Laval, Sainte-Foy, Québec, G1K 7P4, Canada 
and 3Research Institute for Biology of Farm Animals, Wilhelm-Stahl-Allee 2, 18196 Dummerstorf, Germany
Email: Nasser Ghanem - ngha@itw.uni-bonn.de; Michael Hölker - mhoe@itw.uni-bonn.de; Franca Rings - rings@itw.uni-bonn.de; 
Danyel Jennen - djen@itw.uni-bonn.de; Ernst Tholen - etho@itw.uni-bonn.de; Marc-André Sirard - marc-andre.sirard@crbr.ulaval.ca; 
Helmut Torner - torner@fbn-dummerstorf.de; Wilhelm Kanitz - wkanitz@fbn-dummerstorf.de; Karl Schellander - ksch@itw.uni-bonn.de; 
Dawit Tesfaye* - tesfaye@itw.uni-bonn.de
* Corresponding author    
Abstract
Background: Oocyte developmental competence is highly affected by the phase of ovarian follicular wave.
Previous studies have shown that oocytes from subordinate follicles recovered at growth phase (day 3 after
estrus) are developmentally more competent than those recovered at dominance phase (day 7 after estrus).
However, the molecular mechanisms associated with these differences are not well elucidated. Therefore, the
objective of this study was to investigate transcript abundance of bovine oocytes retrieved from small follicles at
growth and dominance phases of the first follicular wave and to identify candidate genes related to oocyte
developmental competence using cDNA microarray.
Results: Comparative gene expression analysis of oocytes from growth and dominance phases and subsequent
data analysis using Significant Analysis of Microarray (SAM) revealed a total of 51 differentially regulated genes,
including 36 with known function, 6 with unknown function and 9 novel transcripts. Real-time PCR has validated
10 transcripts revealed by microarray analysis and quantified 5 genes in cumulus cells derived from oocytes of
both phases. The expression profile of 8 (80%) transcripts (ANAXA2, FL396, S100A10, RPL24, PP, PTTG1, MSX1
and BMP15) was in agreement with microarray data. Transcript abundance of five candidate genes in relation to
oocyte developmental competence was validated using Brilliant Cresyl Blue (BCB) staining as an independent
model. Furthermore, localization of mRNA and protein product of the candidate gene MSX1 in sections of
ovarian follicles at days 0, 1, 3 and 7 of estrous cycle showed a clear fluorescent signal in both oocytes and cumulus
cells with higher intensity in the former. Moreover, the protein product was detected in bovine oocytes and early
cleavage embryos after fertilization with higher intensity around the nucleus.
Conclusion: This study has identified distinct sets of differentially regulated transcripts between bovine oocytes
recovered from small follicles at growth and dominance phases of the first follicular wave. The validation with
independent model supports our notion that many of the transcripts identified here may represent candidate
genes associated with oocyte developmental competence. Further specific functional analysis will provide insights
into the exact role of these transcripts in oocyte competence and early embryonic development.
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Background
In vitro embryo production depends on the collection of
immature oocytes from heterogeneous follicular popula-
tion of slaughterhouse ovaries. Despite the desire to
expand the field application of this technology in cattle,
the blastocyst development is limited to 30–40% with
only half of these being able to initiate a successful preg-
nancy following transfer [1,2]. One of the main factors
affecting the embryo yield is the intrinsic quality of the
oocyte, while the embryo culture condition plays a crucial
role in determining embryo quality [3].
There is a general agreement that oocyte developmental
competence is related to follicule size [4], estrous cycle
stage [5] and the level of atresia influenced by other folli-
cles, mainly the dominant follicle [6] and morphological
features of the oocyte [7]. Follicle size and oocyte diame-
ter are closely related, and as both increase the develop-
mental potential of the oocyte also increases [8-10].
However, various studies revealed that the developmental
competence of an oocyte is related to the status of the fol-
licle from which it is obtained regardless of follicle size
[11-13].
As soon as the primordial follicle store is established, fol-
licle recruitment begins and continues in a wave-like pat-
tern during estrous cycles. Bovine estrous cycle is
characterized by a series of two or three follicular waves
[14-16]. Within several days of initiation of a wave, one
follicle is selected as the dominant follicle, which contin-
ues to grow and differentiate, whereas its sister subordi-
nate follicles plateau in growth and then regress. The
interactions between the follicles throughout each follicu-
lar wave affect oocyte quality. It was reported [6,17-21]
that development of early embryos to the blastocyst stage
was greater when oocytes are obtained during follicular
growth/stagnation phase (G/S) than in the dominance/
regression phase (D/R). The dominant follicle exerts a
direct inhibitory effect on the development of subordinate
follicles [22], causing them to undergo atresia [23], which
lead to lower in vitro developmental competence com-
pared to their counterparts at growth phase [6]. In addi-
tion, blastocysts derived from oocytes collected from both
medium and small follicles at G/S stage or D/R stage were
reported to be different in relative abundance of tran-
scripts related to embryonic development [24].
To our knowledge, the mRNA transcript abundance of
oocytes recovered at different stages of ovarian follicular
turnover in bovine has not yet been analyzed. Therefore,
in the present study we aimed to identify the differences
in the transcript abundance of bovine oocytes retrieved
from small follicles at growth and dominance phases
which could be associated with oocyte developmental
potential. With this approach, we have identified differen-
tially expressed genes in oocytes derived from these two
stages. Differences in transcript abundance of some tran-
scripts of interest between the two oocyte groups and
cumulus cells were examined using quantitative real-time
PCR. An independent model has been used to validate the
expression profile of some selected transcripts in oocytes
screened for differences in their developmental compe-
tence.
In addition, MSX1 gene was selected for further analysis
due to the following reasons: 1) it has also been identified
as differentially regulated transcript between biopsies
derived from blastocysts resulted in pregnancy and no
pregnancy in our previous study [25] 2) results from pre-
vious studies [26,27] suggest a physiologically optimal
level of MSX1 expression is vital for normal cellular func-
tion. However, so far this transcript has not been charac-
terized in early embryonic development and follicular
turnover. The distribution of protein products and mRNA
for MSX1 during ovarian follicular turnover and early
embryonic development has been evidenced in this study.
Results
Follicle distribution and oocyte recovery
As shown in Table 1, ultrasound guided ovum pick up
(OPU) of sixty cyclic heifers showed that ovaries of both
growth and dominance phases had greater number of
small follicles (3–5 mm) than medium and large follicles.
Moreover, a higher number of small and medium follicles
(n = 333) has been found at growth phase compared to
dominance phase (n = 262). Consequently, the average
number of oocytes collected per cow was greater during
growth phase (7.7 ± 3.5) than in the dominance phase
(4.9 ± 2.1).
Comparative transcript abundance of oocytes recovered 
at growth and dominance phases
In the present study, a series of six hybridizations (three
biological replicates with dye swaps) were conducted to
minimize the false positive expression changes and to
identify genes truly differentially expressed between
oocytes recovered from growth and dominance phases.
The generated data are available on our website of Bonn
University [28], under the research section for OPU-IVF.
After LOWESS normalization of the data, log value of Cy5
total intensity was compared with the log value of Cy3
total intensity for both the target (Fig. 1A) and the respec-
tive dye swap hybridizations (Fig. 1B). The coefficient of
determination of the target (R2 = 0.96) and dye swap (R2
= 0.95) hybridizations were found to be relatively the
same which confirms that there was low false positive
expression changes between hybridizations of differen-
tially labeled (Cy5 and Cy3) cDNA from the same phase
(growth and dominance).BMC Developmental Biology 2007, 7:90 http://www.biomedcentral.com/1471-213X/7/90
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To obtain a highly confident set of differentially expressed
genes, we used a rigorous combination of P-value (P <
0.05) and fold discovery rate (FDR) of 10%. Accordingly,
the data analysis performed by SAM showed that 51 tran-
scripts were differentially regulated between the two
oocyte populations. The threshold for significant varia-
tion was set at 1.5 fold change. Using this criterion, genes
were sorted into two categories based on their variation
factor: those for which the relative transcript abundance
increased (up-regulated) or decreased (down-regulated)
in growth phase versus dominance phase oocytes. The
fold change was in a range of 1.5 to 5.3 for up-regulated
and 1.5 to 2.6 for down-regulated genes in growth phase
compared to dominance phase oocytes (Fig. 2, Tab. 2 and
3).
Hierarchical clustering and heatmap of differentially reg-
ulated genes showed the overall expression pattern
between the two oocyte groups. The average linkage clus-
tering analysis revealed the presence of many subgroups
(or clusters) within the up- and down-regulated genes
sharing similar expression pattern (Fig. 2).
Functional classification of differentially regulated genes
All differentially regulated transcripts were functionally
classified based on the criteria of Gene Ontology Consor-
tium classifications [29]. The resulting data were supple-
mented with additional information from various tools
available in National Center for Biotechnology Informa-
tion [30]. Accordingly, the differentially regulated tran-
scripts represent genes with known function (36/51),
genes with unknown function (6/51) and novel tran-
scripts (9/51) (Fig. 3). Regarding the molecular function,
transcripts with known function showed to be involved in
protein biosynthesis (18%), transcription (10%),
cytoskeleton (8%), cell cycle (8%), NADH dehydrogenase
activity (4%), calcium ion binding (4%), nucleotide bind-
ing (4%) and other functions (10%). Oocytes recovered at
growth phase (Tab. 2) were enriched with genes regulat-
ing protein biosynthesis (RPLP0, RPL8, RPL24, ARL6IP,
RpS14, RpS15, RpS4x and RPS3A), translation elongation
(EF1A), ATP binding (ATP5A1), NADH dehydrogenase
activity (FL396 and FL405), cytoskeleton (Actin, beta-
Actin, H2AZ and KRT8), calcium ion binding (S100A10
and ANXA2), signal transduction (G-beta like protein),
Scatter plot illustrating log value of Cy3, Cy5 total intensities for the biological and dye swap (technical) replicates Figure 1
Scatter plot illustrating log value of Cy3, Cy5 total intensities for the biological and dye swap (technical) replicates. Each gene is 
represented by a point of Cy3 and Cy5 log values, A: represents target hybridizations B: represents dye swap hybridizations.
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Table 1: Performance of the OPU procedure at growth and dominance phases of follicular development
Phase of follicular 
development
Follicle size Number of follicles 
aspirated
Number of oocytes 
retrieved
Average number of 
oocytes per animal
Recovery rate
Growth (n = 30) Large - -
Medium 148 88 7.7 ± 3.5 69.4%
Small 185 143
Dominance (n = 30) Large 30 7
Medium 39 20 4.9 ± 2.1 50.7%
Small 223 121BMC Developmental Biology 2007, 7:90 http://www.biomedcentral.com/1471-213X/7/90
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(.)inorganic diphosphatase (PP) and thiol-disulfide
exchange intermediate (TXN). On the other hand, oocytes
recovered at dominance phase (Tab. 3) were encoded
transcripts controlling transcription (MSX1, PTTG1,
FANK1 and PWP1), cell cycle (CCNB1, CKS2, UBE2D3
and CDC31), aldehyde reductase activity (AKR1B1),
Hierarchical clustering and heatmap of 51 differentially expressed genes Figure 2
Hierarchical clustering and heatmap of 51 differentially expressed genes. The red blocks represent up-regulated genes while 
the green blocks represent down-regulated genes in oocytes recovered at growth phase.
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Table 2: Transcripts up-regulated in oocytes recovered at growth phase compared to dominance phase
Gene name Accession No in NBCI GenBank Fold change Gene function
Bos taurus beta-actin mRNA 
complete cds (ACTB)
AY141970 2.4 Structural constituent of 
cytoskeleton
Bovine actin mRNA 3' end (ACT) K00623 3.4 Structural constituent of 
cytoskeleton
Bovine mRNA for histone 
(H2AFZ)
X52318 5.3 Chromosome organization
Bovine mRNA fragment for 
cytokeratin A (no. 8) (KRT8)
X12877 1.8 Cytoskeleton organization and 
biogenesis
Bos taurus S100 calcium-binding 
protein A10 mRNA (S100A10)
NM_174650 3.1 Calcium ion binding
Bos taurus annexin A2 mRNA 
(ANXA2)
NM_174716 4.9 Calcium ion binding
Bos taurus ATP synthase, H+ 
transporting, mitochondrial F1 
complex (ATP5A1)
NM_174684 3.2 ATP binding
Bos taurus isolate FL396 
mitochondrion partial genome
AY308068 1.7 NADH dehydrogenase 
(ubiquinone) activity NADH 
dehydrogenase (ubiquinone) 
activity
Bos taurus isolate FL405 
mitochondrion, partial genome
AY308069 1.7 Structural constituent of ribosome
Bos taurus ribosomal protein L24 
mRNA (RPL24)
NM_174455 1.8 Structural constituent of ribosome
Rattus norvegicus ribosomal 
protein S4, X-linked mRNA 
(Rps4x)
XM_343803 1.7 Structural constituent of ribosome
Homo sapiens ADP-ribosylation 
factor-like 6 interacting protein 
(ARL6IP)
BC010281 1.6 Structural constituent of ribosome
Bos taurus mRNA for similar to 
acidic ribosomal phosphoprotein 
PO (RPLP0)
AB098748 1.7 Structural constituent of ribosome
Homo sapiens ribosomal protein 
L8, mRNA (cDNA clone 
IMAGE:3504599) (RPL8)
BC000047 1.6 Structural constituent of ribosome
Bos taurus mRNA for similar to 
ribosomal protein S3a, partial cds 
(RPS3A)
AB099017 1.5 Structural constituent of ribosome
Bos taurus mRNA for similar to 
ribosomal protein S14, partial cds 
(RPS14)
AB099089 1.5 Structural constituent of ribosome
Homo sapiens ribosomal protein 
S15 mRNA (RPS15)
NM_001018 1.5 Translation elongation factor 
activity
Bos taurus mRNA for elongation 
factor 1 alpha, complete cds 
(EF1A)
AB060107 1.5 Inorganic diphosphatase, 
Phosphatase
Bovine inorganic pyrophosphatase 
mRNA sequence (PP)
M95283 1.8 Thiol-disulfide exchange 
intermediate activity
Bos taurus thioredoxin mRNA 
complete cds (TXN)
AF104105 2.6 Signal transduction
S.scrofa mRNA encoding G-beta 
like protein (GNB2L1)
Z33879 1.5 Unknown
Homo sapiens placenta-specific 8 
mRNA (PLAC8)
NM_016619 1.5 Unknown
PREDICTED: Canis familiaris 
similar to Placenta-specific gene 8 
((PLAC8)
XM_535633 1.5
Differentially expressed genes were identified by SAM at a false discovery rate (FDR) of ≤ 10% and P < 0.05.BMC Developmental Biology 2007, 7:90 http://www.biomedcentral.com/1471-213X/7/90
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nucleotide binding (TUBA6 and K-ALPHA-1), growth fac-
tor (BMP15) and fertilization (ZP4).
Real-time PCR Validation
Real-time PCR analysis using independent oocyte samples
was conducted to validate the array results of 10 differen-
tially regulated transcripts. No differences in relative
abundance of the internal control gene (GAPDH) were
observed in all samples. Based on this, the quantitative
real-time PCR has confirmed the relative abundance of 8
transcripts (80%) to be in agreement with microarray
results (Fig. 4A, B, C). The mRNA relative abundance of
Table 3: Transcripts down-regulated in oocytes recovered at growth phase compared to dominance phase
Gene name Accession No in NBCI GenBank Fold Change Gene function
Bos taurus bone Morphogenetic 
protein 15 mRNA partial cds 
(BMP15)
AY304484 1.8 Growth factor activity
Homo sapiens bone 
morphogenetic protein 15 
precursor gene (BMP15)
AF082350 1.7 Growth factor activity
Bos taurus msh homeo box 
homolog 1 (Drosophila) mRNA 
(MSX1)
NM_174798 1.6 Transcription factor activity
Homo sapiens pituitary tumor-
transforming gene 1 mRNA 
(PTTG1)
NM_004219 1.7 Transcription factor activity
Homo sapiens fibronectin type 3 
and ankyrin repeat domains 1 
mRNA (FANK1)
BC024189 1.5 Transcription factor activity
Bos taurus fibronectin type 3 and 
ankyrin repeat domains 1 (FANK1)
NM_001003904 1.5 Transcription factor activity
Homo sapiens nuclear 
phosphoprotein similar to S. 
cerevisiae (PWP1)
NM_007062 1.5 Cell growth and/or transcription
Homo sapiens CDC28 protein 
kinase regulatory subunit 2 mRNA 
(CKS2)
NM_001827 1.5 Cell cycle
Bos taurus mRNA sequence 
(CCNB1)
L26548 1.6 Regulation of cell cycle 
progression
Homo sapiens centrin, EF-hand 
protein, 3 (CDC31 homolog, 
yeast)
BC005383 1.6 Mitotic centrosome separation
Homo sapiens ubiquitin-
conjugating enzyme E2D 3 (UBC4/
5 homolog) (UBE2D3)
BC003395 1.6 Ubiquitin conjugating enzyme 
activity
Homo sapiens tubulin, alpha, 
ubiquitous, mRNA (cDNA clone 
MGC:4689) (K-ALPHA-1)
BC009509 1.5 Nucleotide binding
Homo sapiens tubulin alpha 6, 
mRNA (cDNA clone MGC:19827) 
(TUBA6)
BC011790 1.5 Nucleotide binding
Bovine aldose reductase mRNA 3' 
end (AKR1B1)
M31463 1.5 Aldehyde reductase activity
Bos taurus zona pellucida 
glycoprotein 4 mRNA (ZP4)
NM_173975 1.5 Binding of sperm to zona pellucida
Rattus norvegicus similar to 
putative nuclear protein 
(LOC307510)
XM_226070 1.7 Unknown
Homo sapiens genomic DNA, 
chromosome 11q, (clone:RP11-
313I2)
AP003122 1.7 Unknown
Homo sapiens BAC clone RP11-
83B6 from 2, complete sequence 
(RP11-83B6)
AC010872 1.5 Unknown
Homo sapiens hypothetical 
protein FLJ14904, mRNA (cDNA 
clone) (FLJ14904)
BC028595 1.5 Unknown
Differentially expressed genes were identified by SAM at a false discovery rate (FDR) of ≤ 10% and P < 0.05.BMC Developmental Biology 2007, 7:90 http://www.biomedcentral.com/1471-213X/7/90
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mRNAs for ANAXA2, S100A10, RPL24, and PP was higher
(P < 0.05) in growth phase compared to dominance phase
oocytes. Greater transcript abundance for MSX1 and
BMB15 was observed in dominance phase versus growth
phase oocytes. However, differences in transcript abun-
dance of FL396 and PTTG1 between the two oocyte
groups were not statistically significant. The array results
of CKS2 and CCNB1 could not be confirmed by real-time
quantitative PCR (Fig. 4A).
Quantitative analysis of selected transcripts in cumulus 
cells
To avoid any biasness in the number of cumulus cells
used as an input for mRNA isolation and subsequent real-
time PCR, cumulus cells were derived from equal number
of cumulus oocyte complexes (COCs) with similar mor-
phological appearance. After mRNA isolation and subse-
quent cDNA synthesis, the relative abundance of GAPDH
gene was tested and showed no variation between these
samples. Two transcripts (MSX1 and FL396) were highly
abundant (P < 0.05) in cumulus cells of dominance phase
than that of growth phase (Fig. 5). On the other hand,
RPL24 and CKS2 transcripts were found to be more abun-
dant in cumulus cells of growth phase compared to that of
dominance phase. The relative abundance of mRNA for
S100A10 was nearly the same in cumulus cells of both
phases.
Validation of relationship between transcript abundance 
and oocyte competence using BCB staining
Immature oocytes screened for developmental compe-
tence based on BCB staining were used for validation of
the expression profile of five transcripts (BMP15, RPL24,
PP, MSX1 and PTTG1). The cDNA synthesized from BCB+
(stained blue) and BCB- (stained colourless) oocyte sam-
ples were quantified using real-time PCR. After confirm-
ing that there were no significant differences in the relative
abundance of GAPDH between the samples, all tran-
scripts were quantified using independent real-time PCR
runs. The relative abundance for MSX1 and PTTG1 were
higher (P < 0.05) in BCB- oocytes than BCB+ ones (Fig. 6).
The BMP15 was also more abundant in BCB- than BCB+
oocytes but differences were not significant. On the other
hand, greater mRNA abundance (P < 0.05) for RPL24 and
PP has been observed in BCB+ than BCB- oocytes (Fig. 6).
Differentially expressed genes as classified based on the Gene Ontology Consortium classifications [29]. Figure 3
Differentially expressed genes as classified based on the Gene Ontology Consortium classifications [29].
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Localization of bovine MSX1 mRNA and protein
Immunofluorescent labelling of MSX1 gene in ovarian
samples collected at the time of estrus (day 0), ovulation
(day 1), growth phase (day 3) and dominance phase (day
7) showed the presence of this protein in all stages of fol-
licular development under investigation. More specifi-
cally, this protein was found to be more localized in the
oocyte cytoplasm than the enclosed cumulus cells (Fig.
7d, h, p) or other cellular layers of the growing follicle
(Fig. 7b, f, n) at all stages of follicular development except
at growth phase (Fig. 7j, l). Furthermore, MSX1 protein
was found to be dispersed in the cytoplasm of immature
and matured oocytes and early zygote (Fig. 8a, b, c) but
tends to be localized around the nucleus at advanced
zygote, 2-cell, 4-cell and 8-cell embryos (Fig. 8d, e, f, g).
Comparative analysis of protein signals between oocytes
showed that green fluorescence signals were reduced after
maturation (Fig. 8b). Moreover, in situ hybridization
experiment showed that MSX1 mRNA was localized in the
oocytes, cumulus cells and follicular wall throughout all
stages of follicular turnover (Fig. 9A, B, C, D, E, F, G, H).
Discussion
Investigation on the molecular characteristics of oocytes
of varying developmental competence is critical for the
development of future classification criteria for the selec-
tion of oocytes with superior developmental capacity
[31]. It has been shown that the molecular causes for poor
developmental capacity of bovine oocytes may be highly
complex and may be reliant on many small changes in the
RNA levels of many genes [32]. However; our understand-
ing of composition of the oocyte transcriptome and the
identity of key oocyte-expressed genes with important reg-
ulatory roles in folliculogenesis and early embryonic
development is far from complete [33]. Thus, our study
mainly focuses on identifications of differences in mRNA
transcript abundance which may be associated with devel-
opmental competence of bovine oocytes using cDNA
microarray as a functional genomics approach.
Quantitative real-time PCR validation of 10 differentially expressed genes in bovine oocytes recovered at growth phase (day 3)  vs. dominance phase (day 7) as identified by microarray analysis (A, B, C) Figure 4
Quantitative real-time PCR validation of 10 differentially expressed genes in bovine oocytes recovered at growth phase (day 3) 
vs. dominance phase (day 7) as identified by microarray analysis (A, B, C). The relative abundance of mRNA levels represents 
the amount of mRNA compared to the calibrator (with the lowest normalized value). Bars with different superscripts (a, b) are 
significantly different at P < 0.05.
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Growing oocytes have higher rate of transcription and
translation resulting in the formation of RNAs and pro-
teins both for oocyte growth and storage [34]. The previ-
ous molecules could be redirected to fulfil new tasks as
resumption of meiosis [35] and regulating maternal to
zygotic transition [36]. Developmental competence of
mammalian oocytes depends on high rates of RNA and
protein synthesis, imprinting processes and biogenesis of
organelles such as mitochondria [37]. Similarly, in the
present study oocytes from the growth phase were found
to be enriched with transcripts related to protein biosyn-
thesis as compared to their dominance phase counter-
parts. An adequate pool of ribosomes, which were
synthesized by transcription of the ribosomal RNA
(rRNA) genes, is required for protein synthesis during
oocyte growth and embryonic development. Failure to
detect one or all of ribosomal RNA (rRNA) genes during
oocyte growth or later during interphase of the first cell
cycle is an indicator of developmental incompetence [38].
This is in agreement with our results that showed the
down-regulation of RPL24 transcript in oocytes from
dominance phase with low developmental potential and
could be validated using BCB screened oocytes. This may
suggest that there is an optimal threshold of mRNA tran-
script abundance for ribosomal RNA genes below which
the developmental competence of the oocytes is compro-
mised.
Various transcription factors are known to be present in
the maternal mRNA store until their recruitment for trans-
lation at the time of maternal-embryonic transition [39].
In the present study, different transcription factors (MSX1,
Quantitative real-time PCR of 5 genes in bovine cumulus cells denuded from oocytes recovered at growth phase (day 3) vs.  dominance phase (day 7) Figure 5
Quantitative real-time PCR of 5 genes in bovine cumulus cells denuded from oocytes recovered at growth phase (day 3) vs. 
dominance phase (day 7). The relative abundance of mRNA levels represents the amount of mRNA compared to the calibrator 
(with the lowest normalized value). Bars with different superscripts (a, b) are significantly different at P < 0.05.
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P T
Quantitative real-time PCR of 5 genes in bovine oocytes treated with brilliant cresyl blue stain [BCB- (colourless cytoplasm,  increased G6PDH activity) and BCB+ (coloured cytoplasm, low G6PDH activity)] Figure 6
Quantitative real-time PCR of 5 genes in bovine oocytes treated with brilliant cresyl blue stain [BCB- (colourless cytoplasm, 
increased G6PDH activity) and BCB+ (coloured cytoplasm, low G6PDH activity)]. The relative abundance of mRNA levels rep-
resents the amount of mRNA compared to the calibrator (with the lowest normalized value). Means without common super-
scripts (a, b) were considered to be significantly different at P < 0.05.
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Subcellular localization of bovine MSX1 protein in bovine oocytes and early cleavage embryonic stages [immature oocyte (a),  matured oocyte (b), zygote (c), advanced zygote (d), 2-cell (e), 4-cell (f) and 8-cell (g)] Figure 8
Subcellular localization of bovine MSX1 protein in bovine oocytes and early cleavage embryonic stages [immature oocyte (a), 
matured oocyte (b), zygote (c), advanced zygote (d), 2-cell (e), 4-cell (f) and 8-cell (g)]. Negative control (h) was processed 
without addition of primary anti-MSX1 antibody. Nuclei are stained with propidium iodide (red). Scale bars represent 20 µm.
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TG1, FANK1 and PWP1) were found to be up-regulated in
dominance phase compared to growth phase oocytes.
MSX gene families encode homeodomain transcription
factors [40] and their protein products control key devel-
opmental processes such as differentiation and patterning
during early development [41]. Overexpression of the
MSX1 suppresses cell growth and cell cycle progression in
human ovarian cancer cell line by regulating the expres-
sion of key cell cycle regulators [42]. In addition, MSX1
has been reported to regulate the p53 tumor suppressor
protein in human tumours and thereby enhances apopto-
sis mediated suppression of p53 [43]. Moreover, mice
MSX1 homozygous mutants die at birth [44]. In a recent
study, MSX1 was more abundant in oocytes with reduced
development competence [31].
Pituitary tumor transforming gene (PTTG1) was isolated
from a pituitary tumor cell line and its over-expression
results in cellular transformation in vitro and tumor for-
mation in nude mice [45]. Moreover, this gene stimulates
expression of the Bax gene, which induces apoptosis in
human embryonic kidney cell line [46]. Consistent with
the previous facts, the enrichment of dominance phase
oocytes with apoptotic related genes (MSX1 and PTTG1)
may be related to the level of atresia in subordinate folli-
cles as influenced by the dominant follicle which may
Immunohistochemical localisation of MSX1 protein in bovine ovarian sections at day of estrus (b, d), day of ovulation (f, h),  growth phase (j, l), dominance phase (m, q) Figure 7
Immunohistochemical localisation of MSX1 protein in bovine ovarian sections at day of estrus (b, d), day of ovulation (f, h), 
growth phase (j, l), dominance phase (m, q). Cumulus cells are marked with Cc and oocytes are marked with Oo. Negative 
controls were processed without addition of primary anti-MSX1 antibody (r, t). Sections were counterstained with toluidine 
blue (a, c, e, g, i, k, m, o, q and s). Images from the same ovarian sections were captured with lower and higher magnification.
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Fluorescent in situ hybridization of MSX1 mRNA conducted with DIG labelled RNA antisense probe in bovine ovarian sections  at day of estrus (A, B), day of ovulation (B, C), growth phase (D, E), dominance phase (F, G) Figure 9
Fluorescent in situ hybridization of MSX1 mRNA conducted with DIG labelled RNA antisense probe in bovine ovarian sections 
at day of estrus (A, B), day of ovulation (B, C), growth phase (D, E), dominance phase (F, G). Cytoplasms of the oocytes (Oo) 
are darkly stained with green fluorescent compared to cumulus cells (Cc). Negative controls were hybridized with DIG 
labelled RNA sense probe (H, I). Images from the same ovarian sections were captured with lower and higher magnification.
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lead to reduced developmental capacity of enclosed
oocytes. In a recent study conducted in our laboratory,
MSX1 and PTTG1 were found to be up-regulated in
embryo biopsies derived from blastocysts which resulted
in no pregnancy after transfer to recipients [25].
Optimal expression of MSX1 as transcription factor seems
to be important for cellular physiology [26,27]. In the
present study, the MSX1 protein was detected in all follic-
ular compartments of the growing follicle at different
stages of follicular turnover and early preimplantation
stages, with a slight decrease in fluorescent intensity in
ovaries at growth phase. As embryonic development pro-
ceeds there is accumulation of the MSX1 protein around
the nucleus of the blastomeres which is consistent with
the localization of homeobox gene family namely cdx2 in
mouse embryos [47]. Furthermore, mRNA for MSX1 was
also distributed in all follicular layers with intensive signal
in the oocytes. As a member of transcription factor gene,
the possible role of MSX1 in regulating follicular turnover
and early embryonic development needs further investi-
gations.
Oocyte growth during folliculogenesis is regulated by
granulosa cell derived proteins [48], which are in turn reg-
ulated by oocyte-derived factors [49]. In addition, cumu-
lus cells provide nutrients for the oocyte and influence
oocyte development in a paracrine fashion [50], and these
paracrine factors contribute to induce meiotic resumption
of oocytes [51]. Characterization of the signalling path-
ways driving changes in transcript abundance for co-regu-
lated and differentially regulated genes in oocytes versus
associated cumulus cells may lead to a better understand-
ing of interdependent gene regulation between germ and
somatic cells [52]. In this study, compared to other candi-
date transcripts the bovine MSX1 was found to be higher
in both oocytes and the corresponding cumulus cells at
dominance phase than those from growth phase. There-
fore, this transcript can be considered as one of the factors
activated in oocyte and cumulus cells from the subordi-
nate follicles due to the presence of the dominant follicle.
Similar studies [53,54] have described the expression pro-
file of some transcripts (cyclooxygenase-2, hyaluronic
acid synthase-2, gremlin, and pentraxin-3) in the cumulus
cells as potential markers of the quality of the enclosed
oocyte.
The BCB staining was used effectively to select bovine
oocytes for further developmental competence after in
vitro fertilization [55] or somatic cell nuclear transfer [56].
Therefore, in the present study, BCB staining was used as
an independent model to screen oocytes for their develop-
mental competence in order to validate the differential
expression of candidate genes identified in array analysis.
Higher abundance of MSX1 and PTTG1 in dominance
phase oocytes in array experiment was consistent with
their higher abundant in BCB- oocytes than in BCB+ ones.
Similarly, the relatively higher abundance of RPL24 and
PP transcripts in oocytes from growth phase was consist-
ent with their higher abundance in BCB+ oocytes. Thus,
there is a clear association of mRNA abundance for genes
detected in microarray experiment and developmental
competence of oocyte tested with BCB staining. The
bovine RPL24 and MSX1 as members of ribosomal pro-
teins and transcription factor gene family, respectively can
be considered as good markers of oocyte developmental
competence, as they showed consistent results in both
models.
Conclusion
The reported differences in developmental competence of
bovine oocytes derived from small follicles at growth and
dominance phases of follicular development are also
accompanied by differences in the relative abundance of
transcripts related to the various molecular events and
processes regulating oocyte competence and follicular
development. Our validation with an independent model
for the relative abundance of some selected transcripts,
supports the notion that many of the transcripts identified
as differentially regulated and described here may repre-
sent marker candidate genes for oocyte developmental
competence. However, the exact role of these transcripts
in controlling oocyte developmental potential needs fur-
ther investigation.
Methods
Experimental animals, estrus synchronization and 
detection
The experimental protocol was carried out according to
the rules and regulations of the German law of animal
protection.
Sixty Simmental cyclic heifers 24 to 30 months old, were
selected based on general clinical examination and nor-
mal ovarian cyclicity as determined by ultrasound scan-
ning. The animals were housed as one group and were fed
grass silage ad libitum. Estrus and subsequent ovulation
were synchronized by two administrations of prostaglan-
din PGF2α (Estrumate, 2 ml i.m, Fa. Essex, Germany) at
11 days interval followed by GnRH injection (Receptal,
2500 IU i.m, Intervet, Unterschleissheim, Germany) on
the day of estrus onset. Estrus was detected after two days
of the last prostaglandin PGF2α treatment. Common
signs of estrus were monitored by visual observation fol-
lowed by careful palpation of ovaries for confirmation.
Ovum pick up (OPU)
OPU was performed at two different phases of follicular
development during the first follicular wave using a total
of 60 heifers at growth phase (day 3 after estrus, n = 30)BMC Developmental Biology 2007, 7:90 http://www.biomedcentral.com/1471-213X/7/90
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and dominance phase (day 7 after estrus, n = 30) for two
sessions of OPU in each phase. The heifers were restrained
in a chute, and given 5 ml of epidural anesthesia (pro-
caine hydrochloride 2%, Selectavet, Munich, Germany).
Using transvaginal ultrasound scanner (Pie Medical 400
Vet, Maastricht, Netherlands) with a 7.5 MHz sector probe
the follicles were visualized on the monitor and counted.
The follicles were classified according to their size into
three categories: small (3–5 mm), medium (6–8 mm) and
large follicles (≥ 9 mm). A 50-cm-long 18-gauge needle
was passed through a needle guide along the polyethylene
housing of the transducer, and carried into the fornix
vagina. After fixing the ovary against the transducer, the
needle was advanced to puncture the vaginal wall to enter
the ovarian follicle. The needle was attached via Teflon
tubing to a 50-ml Falcon tube and vacuum pressure pro-
vided with a regulated vacuum pump (K-MAR-5000B;
William Cook Europe) and adjusted to create a flow rate
of 16–20 ml/min. The follicular content of each heifer was
aspirated individually into modified Parker maturation
medium (MPMM) supplemented with 15% oestrus cow
serum (OCS), 0.5 mM L-glutamine, 0.2 mM pyruvate, 50
µg/ml gentamycin sulphate, 10 µl/ml FSH (Folltropin,
Vetrepharm, Canada) and kept at 39°C in thermos. The
follicular fluid contents were poured into a square grid
dish to facilitate finding of oocytes under a stereomicro-
scope. The collected oocytes were kept in the same matu-
ration medium used for collection before being separated
from the surrounding cumulus cells. Oocytes from each
follicular size category and phase were handled and fro-
zen separately.
Oocytes denudation and storage
In this study, only COCs from the small follicles of the
growth and dominance phases were used for the analysis
of transcript abundance. Cumulus cells were removed
from the oocytes of each phase mechanically in matura-
tion medium supplemented with hyaluronidase 1 mg/ml
(Sigma). Separation of cumulus cells was carefully
checked under a stereomicroscope. Cumulus free oocytes
and the corresponding cumulus cells of each phase were
washed two times in PBS (Sigma) and snap frozen sepa-
rately in cryo-tubes containing 20 µl of lysis buffer [0.8 %
IGEPAL (Sigma), 40 U/µl RNasin (Promega Madison WI,
USA), 5 mM dithiothreitol (DTT) (Promega Madison WI,
USA)]. Finally, samples were stored at -80°C until RNA
extraction.
RNA isolation from oocytes and cumulus cells
Messenger RNA isolation of oocytes and cumulus cells
was performed at four different points during the whole
experiment. 1) A total of six pools, each containing 20
oocytes from growth and dominance phases of follicular
development, were used for array analysis after amplifica-
tion, 2) A total of six pools, each containing 20 oocytes
from growth and dominance phases, were used for real-
time validation of array results, 3) The cumulus cells
detached from the oocytes at the growth and dominance
phases were also used for mRNA isolation and subsequent
expression analysis of selected transcripts, 4) A total of 8
pools of oocytes, each containing 50 oocytes from BCB+
and BCB- categories were used to validate the expression
profile of selected transcripts in oocytes with different
developmental competences. In all cases, mRNA isolation
was performed using Dynabead oligo (dT)25 (Dynal Bio-
tech, Oslo, Norway) according to manufacturer's instruc-
tions. Briefly, oocytes or cumulus cells in lysis buffer were
mixed with 40 µl binding buffer [20 mM Tris HCl with pH
7.5, 1 M LiCl, 2 mM EDTA with pH 8.0] and incubated at
70°C for 5 min to obtain complete lysis of and to release
RNA. Ten microlitres of oligo (dT)25 attached magnetic
bead suspension were added to the samples, and incu-
bated at room temperature for 30 min. The hybridized
mRNA and magnetic beads were washed three times using
washing buffer (10 mM Tris HCL with pH 7.5, 0.15 mM
LiCl, 1 mM EDTA with pH 8.0). For each sample, cDNA
synthesis has been performed using oligo (dT)23 primer
and superscript reverse transcriptase II (Invitrogen, Karl-
sruhe, Germany) except for samples used in array analysis
where the reverse transcription was performed using T7
promotor attached oligo d(T)21 primer.
RNA amplification
First and second-strand cDNA synthesis were carried out
as described in our previous study [25]. Ten amplification
cycles were used during second strand synthesis as this
showed less bias on the representativeness of the original
mRNA population after in vitro transcription [57]. The
cDNA was purified and used for in vitro transcription
using AmpliScribe T7 transcription kit (Epicentre technol-
ogies, Oldendorf, Germany) according to manufacturer's
instructions. Then the amplified RNA (aRNA) was puri-
fied using RNeasy Mini kit (Qiagen, Hilden, Germany)
according to the manufacturer's recommendations.
Finally, the aRNA was eluted in 30 µl RNase free water
from which 8 µl was taken to estimate the yield, purity of
aRNA by gel electrophoresis and UV absorbance reading
at A260/280 using Ultrospec™ 2100 pro UV/Visible Spec-
trophotometer (Amersham Bioscience, Freiburg, Ger-
many).
Aminoallyl indirect labelling and dye coupling
MIAME (Minimum Information About Microarray Exper-
iments) guidelines were adhered to the experimental
design. Two independent labelling reactions were carried
out per aRNA sample pertinent to each biological repli-
cate for dye-swap hybridizations. Accordingly, 3 µg of
aRNA from each oocyte pool representing each follicular
phase of development (growth or dominance) was used
as template in reverse transcription reactions incorporat-BMC Developmental Biology 2007, 7:90 http://www.biomedcentral.com/1471-213X/7/90
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ing amino-modified dUTPs into the cDNA using the
CyScribe Post-Labelling Kit (Amersham Biosciences,
Freiburg, Germany) as described previously [25,57]. The
aminoallyl labelled cDNA samples were purified using
CyScribe™ GFX™ Purification kit (Amersham Biosciences)
after adding 10 µl of 2 M HEPES. The purified Aminoallyl
labelled cDNA was then eluted in 60 µl 0.1 M sodium
bicarbonate. The cDNA samples from each phase were dif-
ferentially labelled indirectly using N-hydroxysuccinate-
derived Cy3 and Cy5 dyes and incubated for 1.5 hrs at
room temperature in dark. At the end of incubation, non
reacting dyes were quenched by adding 15 µl of 4 M
hydroxylamine solution (Sigma) and incubated for 15
min at room temperature in dark. To avoid variation due
to dye coupling, aRNA samples from the same follicular
phase were labelled reversibly either with Cy3 or Cy5 for
dye swaps hybridizations. The reaction was then purified
with CyScribe™ GFX™ Purification kit (Amersham Bio-
sciences, Freiburg, Germany). Samples were finally eluted
in 60 µl elution buffer.
Probe hybridization
Pre-hybridization of the slides was performed by placing
the array slides into a corning GAPS II slide container as
described in El-Sayed et al. [25]. Hybridization and post-
hybridization washes were carried out as previously
described elsewhere [58] with slight modifications. Sam-
ples that were going to be hybridized on specific array
were mixed and dried in speedvac centrifuge (GMI, Inc.
Minnesota, USA) then the pellet was re-suspended in pre-
warmed (42°C) formamid based hybridization buffer [15
µl hybridization buffer (Amersham Bioscience, Freiburg,
Germany), 30µl 100% Formamide, and 15µl DEPC
water]. Yeast tRNA (4 mg/ml) and 2.5 µl of Cot-human
DNA (1 mg/ml) (Invitrogen, Karlsruhe, Germany) were
added in a volume of 2.5 µl each to avoid non specific
hybridisation. The pellet was denatured at 95°C for 5
min, centrifuged briefly and hybridized to the array. The
arrays were covered with glass cover slips (ROTH, Karl-
sruhe, Germany) and fixed in the hybridisation cassettes
(TeleChem International, Inc, CA, USA.) before incuba-
tion in a hybridisation chamber (GFL, Dülmen, Ger-
many) at 42°C for 16–20 hrs. After hybridization, slides
were washed twice with 2× SSC-0.1% SDS buffer for 5 min
at 42°C, then once with 1× SSC, 0.2× SSC and 0.1× SSC
for 5 min each at room temperature. Finally, the slides
were rinsed in RNA free water then in isopropanol for 1
min each and centrifuged at ≥ 2000 rpm for 2 min.
Custom array characterization
Ready made bovine cDNA array (BlueChip) [59] provided
by Centre de Recherche en Biologie de la Reproduction
was used in this study. The glass slide contains 4928 spots
divided into two sub-arrays. Each sub-array was com-
posed of 2304 ESTs randomly selected clones obtained
from four different subtraction suppressive hybridizations
(SSH) made with bovine embryos and tissues (First SSH:
GV oocytes subtracted from somatic tissues, second SSH:
GV oocytes subtracted from day-8 blastocysts, third SSH:
day-8 blastocysts subtracted from GV oocytes and fourth
SSH: day-8 blastocysts subtracted from somatic tissues).
All the clones were spotted in each sub-array for a total of
four replicates per slide. Eleven more samples namely vide
(32 spots), alien1 (8 spots), alien2 (8 spots), GFP (4
spots), GFP1 (4 spots), GFP1/2 (4 spots), GFP1/4 (4
spots), GFP1/8 (4 spots), GFP 1/16 (4 spots) and H20/
DMSO (50 spots) were spotted to be used as negative con-
trols for determination of hybridisation background dur-
ing the statistical analysis. Housekeeping genes including
tubulin (8 spots), ubiquitin (8 spots), β-actin (6 spots)
and actin (8 spots) were also added as positive controls.
Array scanning and data analysis
The slides were scanned using Axon GenePix 4000B scan-
ner (Axon Instruments, Foster City, CA, USA). The Gene-
Pix® Pro 4.0 software (Axon Instruments, CA, USA) was
used to process the images, to find spots, to integrate
robot-spotting files and finally to create reports of spot
intensity data. The LOWESS normalization of microarray
data was performed using GProcessor 2.0a software [60].
The normalised data were used to calculate intensity ratios
of all replicates and to obtain one value per clone. Ratios
were finally log2 transformed and submitted to SAM anal-
ysis. Microarray data analysis was performed using SAM,
free software developed at Stanford University [61]. To get
truly differentially expressed genes, the FDR was set at
10% and P-value of < 0.05. Hierarchical clustering and
heatmap of log2-transformed data for up and down regu-
lated genes were generated using PermutMatrix (version
1.8.2) available at [62]. In addition, average linkage clus-
tering algorithm method was employed [63]. Genes
expressed equally in both samples were not included in
the hierarchical clustering.
Quantitative real-time PCR analysis
To validate the results obtained from microarray analysis,
10 candidate transcripts were selected for further analysis
using real-time quantitative PCR (Tab. 4). Five of these 10
candidates were further quantified in the corresponding
cumulus cells from the oocytes of growth and dominance
phases of follicular development. Furthermore, five tran-
scripts were subjected to real-time quantitative PCR using
cDNA synthesized form BCB+ and BCB- oocytes. In all
cases, quantitative analysis of cDNA samples was per-
formed as described previously [25] in comparison with
the bovine GAPDH gene (endogenous control), and was
run in separate wells using ABI PRISM® 7000 sequence
detection system (Applied Biosystems, Foster City, CA,
USA). Finally quantitative analysis was done using the rel-
ative standard curve method and results were reported asBMC Developmental Biology 2007, 7:90 http://www.biomedcentral.com/1471-213X/7/90
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the relative expression or fold change as compared to the
calibrator after normalization of the transcript level to the
endogenous control [64].
Immunohistochemistry
Eight Simmental cyclic heifers, two of each at day of estrus
(day 0), day of ovulation (day 1), growth phase (day 3)
and dominance phase (day 7) were slaughtered to obtain
ovaries for MSX1 protein localization using immunohis-
tochemistery. Ovaries were embedded in Tissue-Tek
(Sakura Finetek Europe, Zoeterwoude, Netherlands) and
snap-frozen in liquid nitrogen and stored at -80°C until
sectioning. Serial sections of 5µm were cut at -20°C using
rapid sectioning cryostat (Leica microsystem Nussloch
GmbH, Heidelberger, Germany). The sections were
mounted on poly-L-lysine coated slides (Menzel GmbH &
Co. KG, Braunschweig, Germany) then washed twice in
PBS for 5 min and fixed in 4% (w/v) paraformaldehyde in
PBS for 45 min at room temperature. The fixed specimens
were permeabilized for 5 min with 0.2% (v/v) Triton-
X100 (Sigma) in PBS and washed three times with PBS. In
order to inhibit non-specific binding of the antibodies,
samples were subsequently blocked in 3% (w/v) bovine
serum albumin (BSA) in PBS for 1 hr at 37°C. After triple
washing with 0.3% (w/v) BSA in PBS slides were incu-
bated for 15 hrs at 4°C with anti-MSX1 primary polyclo-
nal antibody (Sigma) with a dilution of 1:100. After three
consecutive washes with 0.3% (w/v) BSA in PBS, slides
were further incubated for 1 hr with 1:100 dilutions of
secondary anti-rabbit IgG FITC conjugated antibody
(Sigma). Negative controls were processed in the same
manner by omitting the primary antibody.
Iin vitro produced bovine oocytes (immature, matured)
and early cleavage stages embryos (zygotes, advanced
zygotes, 2-cell, 4-cell, 8-cell) were used for immunohisto-
logical localization of MSX1 protein. Ten oocytes or
embryos from each stage were processed similar to ovar-
ian sections with some modifications. Specimens were
fixed in 4% (w/v) paraformaldehyde in PBS overnight at
4°C and permeabilized by 0.5% (v/v) Triton-X100
(Sigma) in PBS. In order to inhibit non-specific binding of
the antibodies, samples were subsequently blocked in 3%
(w/v) BSA in PBS for 1 hr. The oocytes and embryos were
Table 4: Details of the primers used for real-time quantitative PCR analysis and in situ hybridization
Gene 
name
Gene bank 
accession 
Number
Primer sequences Annealing 
temperature (°C)
Product 
size (bp)
BMP15a AY304484 F: 5'- CTGACGCAAGTGGACACCCTA -3' 60 396
R: 5'- GACACACGAAGCGGAGTCGTA -3'
PTTG1a NM_004219 F: 5'- GAAGAGCACCAGATTGCGC -3' 55 204
R: 5'- GTCACAGCAAACAGGTGGCA -3'
MSX1a NM_174798 F: 5'- AAGGTATCCACAGTCCCCAGC -3' 55 180
R: 5'- TCTGCCTCTCCTGCAAAGTTC -3'
PPa AF170490 F: 5'- GCTGCATCCTACTTGTCGGAA-3' 55 194
R: 5'- TTCCAAACTACAACCGCCTTG -3'
S100A10a NM174681 F: 5'- GGATTTCTGAGCATATGGGACC -3' 55 131
R: 5'- GAGCAAGAGGATGCAAGCAATA -3'
ANXA2a NM_174716 F: 5'- CGTGCTCCAGCTAACAGTTCT-3' 55 139
R: 5'- GGAAAGCCAGGTAATGCGTA-3'
CKS2a NM_001827 F: 5'- CGACGACGAGGAGTTCGAGTA-3' 55 122
R: 5'- CCTGACTCTGCTGAACACCAAG-3'
RPL24a NM_174455 F: 5'- CCGTGCAGTCAAATTCCAAA-3' 55 242
R: 5'- CAACTCGAGGAGCAGAAACCTT-3
FL396a AY308068 F: 5'- CGCCAACACGTCTTATACCAAC-3' 55 201
R: 5'- CTGCGAAGAGGCTTCCAATTAG-3'
CCNB1a L26548 F: 5'- CGATATGGTGCACTTTCCTCC-3' 55 145
R: 5'- TGACCACATTCTTTGCCAGG-3'
GAPDHa BC102589 F: 5'-ACCCAGAAGACTGTGGATGG-3' 60 247
R: 5'-ACGCCTGCTTCACCACCTTC-3'
MSX1b NM_174798 F:5'-AGAAGCAGTACCTGTCCATCG 55 382
R: 5'-GGCCTTCTATGTCAGGTGGTA
MSX1c NM_174798 T7-F:5'- GTAATACGACTCACTATAGGGAGAAGCAGTACCTGTCCATCG 55 382
R: 5'-GGCCTTCTATGTCAGGTGGTA
MSX1d NM_174798 SP6-R:5'- GATTTAGGTGACACTATAGAAGGCCTTCTATGTCAGGTGGTA 55 382
F:5'-AGAAGCAGTACCTGTCCATCG
a The primer used for real-time PCR, b The primer used for DNA template amplification, c The forward primer coupled with T7 promoter 
(underlined) used for sense probe synthesis, d The reverse primer coupled with SP6 promoter (underlined) used for antisense probe synthesis.BMC Developmental Biology 2007, 7:90 http://www.biomedcentral.com/1471-213X/7/90
Page 17 of 19
(page number not for citation purposes)
then incubated for 1 hr at 39°C with 1:100 dilution of
anti-MSX1 primary polyclonal antibody (Sigma-Aldrich,
St Louis, MO, USA). Oocytes and embryos were finally
counterstained with 0.5 µg/ml propidium iodide (Sigma-
Aldrich, St Louis, MO, USA) for 15 min, followed by
washing with PBS. Slides were mounted with Vectashield
mounting medium, covered with coverslip and viewed
under confocal laser scanning microscope (CLSM LSM-
510, Carl Zeiss, Germany).
In situ hybridization
Digoxigenin-labeled riboprobes (MSX1 cDNA, sense and
antisense) were generated by SP6 and T7 polymerases
from linearized pGEM®-T Vector plasmid containing a
382 bp MSX1 cDNA insert (details of primers used Tab. 4)
using Dig-labeling kit (Roche Diagnostics, Mannheim,
Germany), according to the manufacturer's protocol. The
same tissue samples that have been used for immunohis-
tochemistery were serially sectioned of 5µm at -20°C as
mentioned above. All sections were fixed in 4% parafor-
maldehyde at room temperature for 15 min. The RNA
probes (50 ng/µl, sense or antisense) were added to
hybridisation buffer [50% Dextran sulphate, 2.5 M NaCL,
Formamide, 20× SSC, Yeast tRNA (10 mg/ml), 50× Den-
hardt's solution, Fish sperm DNA (10 mg/ml)], denatured
at 80°C for 5 min and incubated overnight at 52°C in
humidified chamber. Posthybridization washes were in
2× SSC (pH = 8), 50% formamide twice at 45°C and three
times at room temperature for 10 min each. Then sections
were treated with 5 µg of RNase A and 50 units of RNase
T1 (Fermentas, Steinheim, Germany) in 2× SSC at room
temperature for 30 min, followed by three times washing
with 2× SSC at room temperature for 10 min each. After
washing with TN buffer (0.1 M Tris, 0.15 M NaCl, pH 7.5)
at room temperature for 5 min, the slides were incubated
with 5% (w/v) blocking buffer (PerKin Elmer, Rodgau
Juegesheim, Germany). Then the slides were incubated in
a humidified chamber overnight at room temperature
with sheep anti-DIG antibody conjugated with horserad-
ish peroxidase (Roth, Karlsruhe, Germany), diluted to
1:100 in buffer 1 containing 1% blocking reagent. After
three times washing with TNT buffer (0.05% Tween 20 in
TN buffer) for 5 min each, the immunoreactions were vis-
ualized by incubating the sections with 0.02% (w/v)
TSA™-Plus Fluorescent System (Perkin Elmer, Rodgau
Juegesheim, Germany). Slides were counterstained with
propidiumiodide (0.5 µg/ml of TNT buffer) and finally
mounted with drop of Vecta shield and covered with a
cover slip before viewed under fluorescence microscope.
Brilliant cresyl blue staining
Oocytes aspirated form slaughter house ovaries were used
for BCB staining. The procedure of BCB staining is done as
described in our previous studies [52,53]. Briefly a total of
500 morphologically good quality immature oocytes were
subjected to 26 µM BCB (B-5388, Sigma-Alderich, Taufen-
kirchen, Germany) diluted in mDPBS for 90 min at
38.5°C in a humidified air atmosphere. After washing the
stained COCs were examined under stereomicroscope
and categorized into two groups according to their cyto-
plasm colouration: oocytes with any degree of blue col-
ouration in the cytoplasm (BCB+) and oocytes without
visual blue colouration (BCB-). From each group, four
pools of oocytes each with 50 oocytes (a total of 200) were
used for mRNA isolation and subsequent real-time PCR
after removal of cumulus cells as described before.
Statistical analysis
The mRNA expression analysis for the studied genes was
performed based on the relative standard curve method.
The relative expression data were analysed using General
Linear Model (GLM) of the Statistical Analysis System
(SAS) software package version 8.0 (SAS Institute Inc.,
NC, USA). Differences among the mean values were tested
using ANOVA followed by a multiple pair wise compari-
son using t-test. Differences of P ≤ 0.05 were considered to
be significant.
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